Filing Details
- Accession Number:
- 0001404644-24-000113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-25 21:29:29
- Reporting Period:
- 2024-11-22
- Accepted Time:
- 2024-11-25 21:29:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1404644 | Neurogene Inc. | NGNE | Pharmaceutical Preparations (2834) | 980542593 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1543663 | Mikail Christine Cvijic | C/O Neurogene Inc. 535 W 24Th Street, 5Th Floor New York NY 10011 | President And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-22 | 24,000 | $20.48 | 76,844 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.33 to $20.92, inclusive. The reporting person undertakes to provide to Neurogene Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- Includes 24,000 shares held jointly by the reporting person and her spouse, David Cvijic.
Billionaire Hedge Funds
